No Data
Scinai Leadership to Showcase Company's CGMP Biologics CDMO and Innovative I&I Pipeline During BIO-Europe 2024
Scinai Immunotherapeutics to Hold Annual Shareholder Meeting
Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of Anti-IL-17A/F VHH Antibodies
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Amir Reichman, CEO of Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Shares Are Trading Higher After the Company Announced It Regained Compliance With the Nasdaq.
Scinai Regains Full Compliance With Nasdaq Listing Requirements
No Data
No Data